Central Nervous System Toxicity Associated with Metronidazole Therapy

  1. RODNEY K. KUSUMI, M.D.;
  2. JOSEPH F. PLOUFFE, M.D.;
  3. ROBERT H. WYATT, M.D.; and
  4. ROBERT J. FASS, M.D.
  1. The Ohio State University College of Medicine;
    Columbus, Ohio

    Excerpt

    Metronidazole is a nitroimidazole compound best known as an antimicrobial agent for treating infections caused by susceptible protozoa and anaerobic bacteria. Neurologic side effects attributed to metronidazole include convulsions (1) and sensory polyneuropathy (2-4). We describe here the occurrence of encephalopathy, cerebellar dysfunction with ataxia, and sensory neuropathy associated with high-dose metronidazole therapy.

    A 45-year-old woman underwent a right radical mastectomy in 1965 for breast carcinoma. She subsequently received radiation therapy and chemotherapy with cyclophosphamide and 5-fluorouracil. She did well until June 1978 when she developed a draining chest-wall lesion secondary to radiation necrosis. A pedicle flap was constructed to

    This 100-word excerpt has been provided in the absence of an abstract.

    « Previous | Next Article »Table of Contents